Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PALISADE BIO, INC. Director's Dealing 2014

Sep 5, 2014

35274_dirs_2014-09-05_71c83e15-9fa5-4a58-a3a9-8b401b841ad1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2014-04-03

Reporting Person: JOHE KARL (Director, Chief Scientific Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-03 Common Stock G 17500 Acquired 495747 Direct

Footnotes

F1: Disclosing a previously declared bonafde gift of 17,500 common shares by Reporting Person. The gift was never consummated and the Reporting Person's ownership is being adjusted accordingly.